Same coin..two faces:
Merck has made significant progress with its COVID-19 pill, Molnupiravir. The U.S. has purchased over $2 billion of the pills in 2021, and Britain made history by becoming the first country to approve Molnupiravir for treating mild-to-moderate COVID-19. However, Merck also owns ivermectin, a controversial drug that some think could be used to treat patients with COVID-19.

In response VAL THOR to his Publication

Only people mentioned by @Truth_ in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from anna justice, click on at the bottom under it